Lista de obras -

A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis

scientific journal article

Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway

artículo científico publicado en 2009

Age-associated downregulation of vasohibin-1 in vascular endothelial cells

artículo científico publicado en 2016

Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.

artículo científico publicado en 2011

Angiogenesis and vascular maturation in neuroendocrine tumors.

artículo científico publicado en 2014

Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1

artículo científico publicado en 2012

Antiangiogenic Therapy for Diabetic Nephropathy

artículo científico publicado en 2017

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.

artículo científico publicado en 2018

Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis

artículo científico publicado en 2009

Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release

artículo científico publicado en 2016

Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis

artículo científico publicado en 2004

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells

artículo científico publicado en 2013

Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice

artículo científico publicado en 2009

Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression

artículo científico publicado en 2018

Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis

artículo científico publicado en 2010

Enhanced cancer metastasis in mice deficient in vasohibin-1 gene

artículo científico publicado en 2013

Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.

artículo científico publicado en 2014

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

artículo científico publicado en 2008

Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.

artículo científico publicado en 2008

Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells

artículo científico publicado en 2005

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury

artículo científico publicado en 2020

Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells

artículo científico publicado en 2002

Hepatic fibrosis and angiogenesis after bile duct ligation are endogenously expressed vasohibin-1 independent

artículo científico publicado en 2015

High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma

artículo científico publicado en 2018

Immunohistochemistry of Vasohibin-2 in Human Kidney Disease : Implications in Impaired Glucose Tolerance and Reduced Renal Function

artículo científico publicado en 2017

Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor

artículo científico publicado en 2009

In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer

artículo científico publicado en 2013

Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts

artículo científico publicado en 2009

Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin

artículo científico publicado en 2006

Knockout of Vasohibin-1 Gene in Mice Results in Healthy Longevity with Reduced Expression of Insulin Receptor, Insulin Receptor Substrate 1, and Insulin Receptor Substrate 2 in Their White Adipose Tissue.

artículo científico publicado en 2017

MS-818 accelerates mobilization of endothelial progenitor cells and differentiation to endothelial cells

artículo científico publicado en 2004

Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis

artículo científico publicado en 2005

Metronomic scheduling of a cyclic hexapeptide Ra-VII for anti-angiogenesis, tumor vessel maturation and anti-tumor activity.

artículo científico publicado en 2006

Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin

artículo científico publicado en 2006

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells.

artículo científico publicado en 2011

Pigpen, a nuclear coiled body component protein, is involved in angiogenesis

artículo científico publicado en 2010

Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells.

artículo científico publicado en 2016

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) affects RhoA activation in endothelial cells

scientific article published on 01 June 2007

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins

artículo científico publicado en 2002

Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis

artículo científico publicado en 2004

Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes ⬇️

artículo científico publicado el 1 de junio de 2012

Renal distribution of Vasohibin-1 in patients with chronic kidney disease.

artículo científico publicado en 2014

Renal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model

scientific article published on 15 May 2019

Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts

artículo científico publicado en 2017

Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation

scientific journal article

Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas

artículo científico publicado en 2010

Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis

artículo científico publicado en 2009

Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.

artículo científico publicado en 2011

Targeting angiogenesis and lymphangiogenesis in kidney disease

artículo científico publicado en 2020

Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.

artículo científico publicado en 2017

The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival

artículo científico publicado en 2015

The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells

artículo científico publicado en 2006

Transcriptional regulation of angiogenesis-related puromycin-insensitive leucyl-specific aminopeptidase in endothelial cells

artículo científico publicado en 2004

Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1.

artículo científico

Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors

artículo científico publicado en 2020

Urinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.

artículo científico publicado en 2014

Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene

artículo científico publicado en 2004

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

artículo científico publicado en 2004

Vasohibin prevents arterial neointimal formation through angiogenesis inhibition

artículo científico publicado en 2006

Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma

artículo científico publicado en 2017

Vasohibin-1 and miR-720 expression in diffuse pulmonary capillary hemangiomatosis-like changes associated with pulmonary hypoplasia

artículo científico publicado en 2020

Vasohibin-1 and retinal pigment epithelium

artículo científico publicado en 2012

Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast

artículo científico publicado en 2010

Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction

artículo científico publicado en 2014

Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis

artículo científico publicado en 2009

Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors

scientific article published on 19 February 2016

Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.

artículo científico publicado en 2008

Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma

artículo científico publicado en 2013

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy

artículo científico publicado en 2009

Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms But Not Abdominal Aortic Aneurysms Nor Atherosclerosis in ApoE Deficient Mice

artículo científico publicado en 2020

Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis

artículo científico publicado en 2012

Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling

artículo científico publicado en 2017

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis

artículo científico publicado en 2014

Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma

artículo científico publicado en 2019

Lista de obras de

A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis

Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway

Age-associated downregulation of vasohibin-1 in vascular endothelial cells

Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.

Angiogenesis and vascular maturation in neuroendocrine tumors.

Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1

Antiangiogenic Therapy for Diabetic Nephropathy

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.

Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis

Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release

Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells

Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice

Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression

Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis

Enhanced cancer metastasis in mice deficient in vasohibin-1 gene

Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.

Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury

Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells

Hepatic fibrosis and angiogenesis after bile duct ligation are endogenously expressed vasohibin-1 independent

High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma

Immunohistochemistry of Vasohibin-2 in Human Kidney Disease : Implications in Impaired Glucose Tolerance and Reduced Renal Function

Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor

In vivo delivery of siRNA targeting vasohibin-2 decreases tumor angiogenesis and suppresses tumor growth in ovarian cancer

Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts

Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin

Knockout of Vasohibin-1 Gene in Mice Results in Healthy Longevity with Reduced Expression of Insulin Receptor, Insulin Receptor Substrate 1, and Insulin Receptor Substrate 2 in Their White Adipose Tissue.

MS-818 accelerates mobilization of endothelial progenitor cells and differentiation to endothelial cells

Metallothionein 1 is a downstream target of vascular endothelial zinc finger 1 (VEZF1) in endothelial cells and participates in the regulation of angiogenesis

Metronomic scheduling of a cyclic hexapeptide Ra-VII for anti-angiogenesis, tumor vessel maturation and anti-tumor activity.

Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells.

Pigpen, a nuclear coiled body component protein, is involved in angiogenesis

Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells.

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) affects RhoA activation in endothelial cells

Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins

Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis

Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes ⬇️

Renal distribution of Vasohibin-1 in patients with chronic kidney disease.

Renal tubular injury exacerbated by vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model

Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts

Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation

Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas

Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis

Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.

Targeting angiogenesis and lymphangiogenesis in kidney disease

Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.

The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival

The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells

Transcriptional regulation of angiogenesis-related puromycin-insensitive leucyl-specific aminopeptidase in endothelial cells

Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1.

Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors

Urinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.

Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

Vasohibin prevents arterial neointimal formation through angiogenesis inhibition

Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma

Vasohibin-1 and miR-720 expression in diffuse pulmonary capillary hemangiomatosis-like changes associated with pulmonary hypoplasia

Vasohibin-1 and retinal pigment epithelium

Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast

Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction

Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis

Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors

Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.

Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy

Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms But Not Abdominal Aortic Aneurysms Nor Atherosclerosis in ApoE Deficient Mice

Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis

Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis

Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma